SCHEMBL3977528

SCHEMBL3977528

N#Cc1c(O)ccc(C(=O)OC(=O)c2occ(COC(=O)Nc3ccccc3)c2-c2ccccc2)c1C(=O)NN

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 3/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 3/20 0.33
UBE2N P61088 1/20 0.33
TDP1 Q9NUW8 3/20 0.32
MGLL Q99685 1/20 0.32
ENPP2 Q13822 1/20 0.31
SMN1; SMN2 Q16637 4/20 0.31
LMNA P02545 3/20 0.30
MEN1 O00255 3/20 0.30
KMT2A Q03164 3/20 0.30
HTT P42858 2/20 0.30
NPSR1 Q6W5P4 2/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
HPGD P15428 1/20 0.30
PPARG P37231 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3984992 0.88 KDM4E (0.35) GAAALDH1A1KDM4EPOLBMAPT
SCHEMBL3978604 0.87 TDP1 (0.32) GAAALDH1A1KDM4EPOLBTDP1
SCHEMBL3974971 0.87 ALDH1A1 (0.38) GAAALDH1A1KDM4EMAPTUBE2N
SCHEMBL3978288 0.87 ALDH1A1 (0.34) GAAALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL4248617 0.86 ALDH1A1 (0.33) GAAALDH1A1KDM4EPOLBHPGD
SCHEMBL3981371 0.83 TACR1 (0.38) GAAALDH1A1KDM4EPOLBHPGD
SCHEMBL3975937 0.83 ALDH1A1 (0.36) GAAALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL3980870 0.81 IKBKB (0.34) GAAALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL4282780 0.80 GAA (0.32) GAAALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL3976701 0.80 ENPP2 (0.45) MGLLENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 GAA 1023/4885ALDH1A1 1389/4885KDM4E 2769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.